MUMBAI, India, Sept. 7 -- Intellectual Property India has published a patent application (202617081886 A) filed by Blossomhill Therapeutics, Inc. on July 02, 2026, for Indazole Macrocycle Polymorphs.
Inventors include Rogers, Evan W.; Cui, Jingrong Jean; Rui, Eugene Yuanjin; Shao, Z. Jesse; Garrido-Montalban, Antonio; Jiang, Wanlong; and Chang, Chialu K..
The application for the patent was published on September 04, 2026, under issue no. 36/2026.
Abstract: This disclosure relates to polymorphs of (17E)-16-ethyl-8,12,14-trimethyl-2,11,12,14-tetrahydro-8H-3,5-ethenotripyrazolo[3,4-f:3',4'-j:4'',3''- n][1,4]oxazacyclopentadecin-13(10H)-one that are useful in the treatment of disease, such as cancer, in mammals. This disclosure also relates to compositions including such polymorphs, and to methods of using such compositions in the treatment of diseases, such as cancer, in mammals, especially in humans.
Disclaimer: Curated by HT Syndication.
